Description
Manufacturer:
Sun Pharmaceutical Industries Ltd
Salt Composition:
Levodopa + Carbidopa (CR denotes Controlled Release)
Description:
Syndopa CR 125mg Tablet is a combination medication used to manage the symptoms of Parkinson’s disease. It contains two active ingredients: levodopa and carbidopa. Levodopa is converted to dopamine in the brain, replacing the dopamine that is lost in Parkinson’s disease, which helps to improve motor symptoms like tremors, rigidity, and slowness of movement.
Carbidopa is a dopa decarboxylase inhibitor that prevents the breakdown of levodopa in the bloodstream, allowing more levodopa to reach the brain and reducing peripheral side effects like nausea. The “CR 125mg” indicates a controlled-release formulation containing a specific amount of levodopa (likely 100mg) and carbidopa (likely 25mg), designed to provide a more sustained release of the medication and help maintain smoother symptom control over a longer period.
Syndopa CR is usually taken orally, and the dosage and frequency are individualized based on the patient’s needs and response to treatment.
Reviews
There are no reviews yet.